AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 14 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has confirmed that it is in the process of reviewing a petition for a health claim that suggests the consumption of soy protein-based foods may reduce the risk of certain types of cancer including breast, prostate, and colon cancer.
The Solae Company submitted the petition with the government agency in order to seek approval for the health claim, which focuses on 58 studies supporting the relationship between the consumption of soy protein-based foods and the reduced risk of developing these types of cancer.
"We have worked diligently for the past 3 years to compile existing research and review emerging data regarding the role soy protein-based foods play in reducing the risk of certain types of cancer," stated Lin Yan, director of cancer research for The Solae Company. "We are pleased that the FDA has decided to accept our petition for review. And we are looking forward to the agency's evaluation."
The process for compiling the health claim petition included a comprehensive evaluation by The Solae Company of scientific research that investigated soy protein-based foods and the reduced risk of developing certain types of cancer. Subsequently, the company worked with external experts in the field and meta-analyses (statistical procedures designed to analyze associated results across independent studies) were conducted. This careful process and the weight of the scientific evidence led to the decision to file the petition with the FDA.
Researchers from The Solae Company's Health & Nutrition and Nutraceuticals team were responsible for spearheading the research results on which the petition is based. Several other leading researchers were involved in the scientific review of the data and supported the decision of The Solae Company to file the petition with the FDA. External reviewers of the petition included researchers ...
Source: HighBeam Research, FDA reviews health claim petition regarding reduction in cancer risk.